v3.26.3
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 98,753,102 $ 2,812,921
Restricted cash 4,242,314 4,386,659
Loan receivable 2,101,400
Deferred offering costs 1,295
Prepayment and other current assets, net 2,459,200 98,664,545
Total current assets 107,557,311 105,864,125
Non-current assets    
Non-marketable investment, net
Total non-current assets
Total assets 107,557,311 105,864,125
Current liabilities    
Accrued expenses and other payables 1,711,915 1,762,829
Advance from customers 4,242,314 4,386,659
Tax payables 30,451 30,451
Total current liabilities 5,984,680 6,179,939
Total liabilities 5,984,680 6,179,939
COMMITMENTS AND CONTINGENCIES (Note 8)
SHAREHOLDERS’ EQUITY    
Common stock (112,500,000 Class A ordinary shares authorized; US$0.04 par value as of June 30, 2026 and US$0.40 par value for retroactively restated shares as of December 31, 2025; 231,129 shares and 178,980 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.*) 9,245 71,592
Additional paid-in capital 132,064,308 129,639,826
Accumulated deficit (30,500,922) (30,027,232)
Total shareholders’ equity 101,572,631 99,684,186
Total liabilities and shareholders’ equity $ 107,557,311 $ 105,864,125